Agenda
Programs
Breakout Discussions
Short Courses
Plenary Keynotes
Speaker Biographies
Attendees
1-on-1 Networking
Archives
Sponsor/Exhibitor
Attendee Demographics + Event Features
Sponsorship Opportunities
Current Sponsors
2021 Re-Sign Floorplan
Exhibit Services Schedule
Exhibitor Prospectus
Lead Generation Opportunities
FAQs
Sponsor & Exhibitor Portal
Media
Media Partners
Downloads
Newsroom
Virtual Event Benefit Comparison
Posters
Poster Information
Poster Titles
Register
Event Registration
Group Registration
Press
Warning!
Web API Url is not set.
#BostonDOT20
2020 Conference Programs
September 16 - 17
Target Identification and Validation – Part 1
RNA as a Drug Target
PROTACs and Targeted Protein Degradation – Part 1
Lead and Candidate Selection for Therapeutic Proteins
Antibodies Against Membrane Protein Targets – Part 1
Small G Proteins
Immunology and Oncology
Targeting NASH
Disease Modeling
CNS, Gene and Cell Therapy
September 17 - 18
Target Identification and Validation – Part 2
Lead Generation Strategies
PROTACs and Targeted Protein Degradation – Part 2
Modality Selection for Next-Gen Biotherapeutics
Antibodies Against Membrane Protein Targets – Part 2
Kinase Inhibitor Discovery
GPCR-Based Drug Discovery
Targeting Fibrosis
Preclinical Strategies, Models and Tools in Oncology
Clinical and Translational Biomarkers